Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Biopol ChemicalsNSE:BIOPOL +0.31%20 EBITDA per Share is ₹ as of Mar. 2026. GuruFocus rates NSE:BIOPOL with a GF Score™ of 20/100. The stock has 4 warning signs investors should review. Among 1,408 Chemicals companies, Biopol Chemicals ranks worse than 71022.66% on this metric.
Biopol Chemicals's EBITDA per Share for the
six
months ended in Mar. 2026 was ₹9.37.
Biopol Chemicals does not have enough years/quarters to calculate its EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2026.
During the past 12 months, the average EBITDA per Share Growth Rate of Biopol Chemicals was 175.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.
The historical rank and industry rank for Biopol Chemicals's EBITDA per Share or its related term are showing as below:
NSE:BIOPOL's 3-Year EBITDA Growth Rate is not ranked *
in the Chemicals industry.
Industry Median: 0.85 * Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
During the past 12 months, the average EBITDA Growth Rate of Biopol Chemicals was 111.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.
Biopol Chemicals (NSE:BIOPOL) EBITDA per Share Explanation
EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.
While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.
The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.
EBITDA can be thought of as the cash a business generates that is available to:
Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners
EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.
A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.
Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.
Be Aware
Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.
EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.
Biopol Chemicals EBITDA per Share Related Terms
Biopol Chemicals EBITDA per Share Historical Data
* Premium members only.
The historical data trend for Biopol Chemicals's EBITDA per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Biopol Chemicals's EBITDA per Share for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biopol Chemicals (NSE:BIOPOL) has a EBITDA per Share of ₹ as of Mar. 2026. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Biopol Chemicals and its competitors. According to the industry distribution chart, Biopol Chemicals ranks #999999 out of 1408 companies in the Chemicals industry.
Is Biopol Chemicals' EBITDA per Share too high?
Biopol Chemicals' current EBITDA per Share is ₹. Based on the distribution chart, Biopol Chemicals ranks #999999 out of 1408 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Biopol Chemicals has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Biopol Chemicals' EBITDA per Share compare to LIN and SHW?
According to the Chemicals industry distribution chart, Biopol Chemicals ranks #999999 out of 1408 companies for EBITDA per Share. This places Biopol Chemicals in the lower half of its industry. The industry median EBITDA per Share is 0.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA per Share for a Chemicals company?
The median EBITDA per Share among Chemicals companies is 0.85, based on 1,408 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA per Share significantly above this median, while those in the bottom quartile fall well below. However, EBITDA per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA per Share mean?
A high EBITDA per Share can signal that a stock is expensive relative to its fundamentals. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Biopol Chemicals and its competitors. For the Chemicals industry, the median EBITDA per Share is 0.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biopol Chemicals's current EBITDA per Share is ₹. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biopol Chemicals stock overvalued right now?
Biopol Chemicals (NSE:BIOPOL) has a current EBITDA per Share of ₹. The current EBITDA per Share is ₹. Biopol Chemicals' overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA per Share calculated?
EBITDA per Share is calculated from a company's financial statements. For Biopol Chemicals (NSE:BIOPOL), the current EBITDA per Share is ₹ as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AddressStreet No 372 Action Area 1, Unit No 2ES3B1, 2nd Floor Mani Casadona, IIF Newtown Alia University, North 24 Parganas, Chakpachuria, New town, WB, IND, 700160
Biopol Chemicals Ltd is engaged in the business of trading, manufacturing and distribution of specialty chemicals under the categories of silicones, emulsifiers, biochemicals and polyelectrolytes. Its product portfolio consists of silicone-based products, emulsifier-based products, biochemical products and polyelectrolyte products. It serves various industry segments, including softeners, emulsions and hardeners for textiles; silicone fluids and cleaning chemicals for home care; silicone adjuvants and surfactants in agriculture; and release agents in industrial chemicals. The majority of the company's revenue is derived from the sale of its products to customers in the textile sector.
20GF Score
Get the complete analysis for NSE:BIOPOL
EBITDA per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:BIOPOL has been successfully added to your 
